Patents by Inventor Stephen R. Fransen

Stephen R. Fransen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6830336
    Abstract: A method of acquiring images of the ocular fundus includes software processing acquired images to determine which areas of the fundus have been imaged and comparison software for determining which regions of the fundus need to be imaged but have not been thus far. Based on the processing and comparison, audible or visible feedback is provided to the patient prompting them to shift their line of sight so as to enable the capturing of the remaining regions of the fundus.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: December 14, 2004
    Assignee: Inoveon Corporation
    Inventor: Stephen R. Fransen
  • Publication number: 20040085514
    Abstract: A method of acquiring images of the ocular fundus includes software processing acquired images to determine which areas of the fundus have been imaged and comparison software for determining which regions of the fundus need to be imaged but have not been thus far. Based on the processing and comparison, audible or visible feedback is provided to the patient prompting them to shift their line of sight so as to enable the capturing of the remaining regions of the fundus.
    Type: Application
    Filed: November 1, 2002
    Publication date: May 6, 2004
    Inventor: Stephen R. Fransen
  • Publication number: 20030009356
    Abstract: The present invention relates to a method for improving the delivery of health care for patients. A first data signal being multimedia data which is indicative of a patient condition of a selected patient is input into a local computer. Clinical data, cost data and administrative data relating to the health of the selected patient is also input into the local computer. The first data signal is combined with the clinical data, cost data and administrative data to form a first patient information signal which is transmitted to a central computer. A predetermined disease stage is then assigned to the selected patient based on the first data signal. The disease stage is combined with the first patient information signal to form a second patient information signal. Then, a first array of risk factors is computed from a database containing a plurality of previously obtained individualized patient information records.
    Type: Application
    Filed: July 26, 2002
    Publication date: January 9, 2003
    Inventors: P. Lloyd Hildebrand, Stephen R. Fransen, Gene M. Soderstrom Hopper
  • Patent number: 6470320
    Abstract: The present invention relates to a method for improving the delivery of health care for patients. A first data signal being multimedia data which is indicative of a patient condition of a selected patient is input into a local computer. Clinical data, cost data and administrative data relating to the health of the selected patient is also input into the local computer. The first data signal is combined with the clinical data, cost data and administrative data to form a first patient information signal which is transmitted to a central computer. A predetermined disease stage is then assigned to the selected patient based on the first data signal. The disease stage is combined with the first patient information signal to form a second patient information signal. Then, a first array of risk factors is computed from a database containing a plurality of previously obtained individualized patient information records.
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: October 22, 2002
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: P. Lloyd Hildebrand, Stephen R. Fransen, Gene M. Soderstrom Hopper
  • Patent number: 5940802
    Abstract: A method for improving the delivery of health care for patients. A first data signal being multimedia data which is indicative of a patient condition of a selected patient is input into a local computer. Clinical data, cost data and administrative data relating to the health of the selected patient are also input into the local computer. The first data signal is combined with the clinical data, cost data and administrative data to form a first patient information signal which is transmitted to a central computer. A predetermined disease stage is then assigned to the selected patient based on the first data signal. The disease stage is combined with the first patient information signal to form a second patient information signal. Then, a first array of risk factors is computed from a database containing a plurality of previously obtained individualized patient information records.
    Type: Grant
    Filed: March 17, 1997
    Date of Patent: August 17, 1999
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: P. Lloyd Hildebrand, Stephen R. Fransen, Gene M. Soderstrom Hopper
  • Patent number: 5530254
    Abstract: The present invention comprises an in vitro system called the Diffusion Matrix Vessel and a method of using fluorokinetic analysis for quantifying the diffusion of a fluorescent material through the vessel and thereby characterizing the permeability of the vessel. The results obtained from the gel can be used to verify and develop protocols for investigating and treating angiopathies of the eye related to blood vessel permeability.
    Type: Grant
    Filed: August 22, 1994
    Date of Patent: June 25, 1996
    Assignee: The Board or Regents of the University of Oklahoma
    Inventors: Stephen R. Fransen, P. Lloyd Hildebrand
  • Patent number: 5340991
    Abstract: The present invention comprises an in vitro system called the Agarose Gel Vessel and a method of using fluorokinetic analysis for quantifying the diffusion of a fluorescent material through the agarose gel vessel and thereby characterizing the permeability of the vessel. The results obtained from the gel can be used to verify and develop protocols for investigating and treating angiopathies of the eye related to blood vessel permeability.
    Type: Grant
    Filed: May 21, 1993
    Date of Patent: August 23, 1994
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Stephen R. Fransen, P. Lloyd Hilderbrand